{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:40:02Z","timestamp":1750542002297,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We present a 14-year-old adolescent boy with Hodgkin lymphoma. He had prior completed chemotherapy with ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) regimen followed by bone marrow transplantation 6 months ago. Currently, he has neither specific clinical complaint nor receiving any specific medication. Follow-up FDG PET\/CT scan demonstrated diffuse increased metabolic activity in the entire body subcutaneous tissue. This finding is rarely reported in the literature and may represent an underlying active inflammatory process, most likely attributed to the received treatments. This could impair the diagnostic quality of the scan, affecting the image interpretation, and should be recognized when present.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003413","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T23:03:14Z","timestamp":1606258994000},"page":"e226-e227","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Diffuse Subcutaneous Metabolic Activity in Post Bone Marrow Transplant Hodgkin Lymphoma"],"prefix":"10.1097","volume":"46","author":[{"given":"Abtin","family":"Doroudinia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Payam","family":"Mehrian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Rouhizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"813","DOI":"10.20344\/amp.8712","article-title":"Metabolic activity in the visceral and subcutaneous adipose tissues by FDG-PET\/CT in obese patients","volume":"30","year":"2017","journal-title":"Acta Med Port"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"E739","DOI":"10.1210\/jc.2014-3896","article-title":"Clinical and biochemical factors associated with area and metabolic activity in the visceral and subcutaneous adipose tissues by FDG-PET\/CT","volume":"100","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4103\/0972-3919.112726","article-title":"Hypermetabolic subcutaneous fat in patients on highly active anti-retroviral therapy treatment: subtle finding with implications","volume":"27","year":"2012","journal-title":"Indian J Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/RLU.0000000000002216","article-title":"18F-FDG PET\/CT with diffusely high FDG uptake throughout subcutaneous adipose tissues","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/RLU.0000000000002862","article-title":"Nivolumab-induced subcutaneous fat necrosis: another FDG-avid immune-related adverse event","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00247-019-04574-3","article-title":"18F-2-fluoro-2-deoxyglucose uptake in white adipose tissue on pediatric oncologic positron emission tomography (PET)\/computed tomography (CT)","volume":"50","year":"2020","journal-title":"Pediatr Radiol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MNM.0000000000000697","article-title":"Usual and unusual pitfalls of 18F-FDG-PET\/CT in lymphoma after treatment: a pictorial review","volume":"38","year":"2017","journal-title":"Nucl Med Commun"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1097\/RLU.0000000000002863","article-title":"18F-FDG PET\/CT-guided diagnosis and evaluation of treatment response to cyclosporine a in maldistributed subcutaneous panniculitis-like T-cell lymphoma without typical skin rash","volume":"45","year":"2020","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:05:31Z","timestamp":1750539931000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003413","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2020,11,24]]}}}